Interleukin-6 Therapy Improves Intestinal Recovery Following Ischemia.

J Surg Res 2019 07 1;239:142-148. Epub 2019 Mar 1.

Department of Surgery, Section of Pediatric Surgery, Indianapolis, Indiana; The Indiana University School of Medicine, Indianapolis, Indiana; Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana. Electronic address:

Background: Interleukin-6 (IL6) has both proinflammatory and anti-inflammatory pathways, but its effects on intestinal recovery following ischemia are unknown. We hypothesized that administration of IL6 following intestinal ischemia would improve mesenteric perfusion and mucosal injury.

Methods: Adult male C57Bl6J mice were anesthetized, and a laparotomy was performed. Baseline intestinal perfusion was assessed by laser Doppler imaging. Intestinal ischemia was induced for 60 min by temporarily occluding the superior mesenteric artery. After ischemia, treatments were administered intraperitoneally before closure (Vehicle: 250 μL phosphate-buffered-saline, IL6 low dose (20 ng), IL6 medium dose (200 ng), or IL6 high dose (2 μg)). Animals were allowed to recover for 24 h, were reanesthetized, and their mesenteric perfusion was reassessed. Perfusion was expressed as percentage of baseline. Animals were then sacrificed, and the intestines were explanted for histological analysis. Separate frozen samples were homogenized and analyzed by ELISA for vascular endothelial growth factor (VEGF) and interferon gamma-induced protein 10.

Results: IL6 increased mesenteric perfusion in low dose groups only, whereas it improved postischemic mucosal injury scores in both low and medium dose groups. No differences in perfusion or histology were seen when high dose IL6 was utilized. Intestinal VEGF was higher in the low dose IL6 group compared to vehicle, whereas IP-10 levels were lower in low and medium dose groups compared to vehicle. No differences were noted compared to vehicle in intestinal VEGF and IP-10 with high dose IL6 therapy.

Conclusions: Lower doses of IL6 may serve as effective therapy to decrease intestinal injury after ischemia. Further studies are needed to elucidate the downstream mechanisms before widespread clinical use.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2019.02.001DOI Listing
July 2019
4 Reads

Publication Analysis

Top Keywords

medium dose
12
compared vehicle
12
high dose
12
mesenteric perfusion
12
dose il6
12
low dose
12
dose groups
12
il6
10
dose
9
intestinal vegf
8
low medium
8
intestinal ischemia
8
recovery ischemia
8
intestinal
8
intestinal recovery
8
perfusion
6
ischemia
6
low
5
analyzed elisa
4
homogenized analyzed
4

Similar Publications